Eris Lifesciences Rajeev Dalal Completes Tenure as Independent Director

Mr. Rajeev Dalal’s tenure as a Non-Executive, Independent Director at Eris Lifesciences concluded on December 18, 2025. Appointed on December 19, 2020, following approval at the Annual General Meeting on September 1, 2021, his five-year term has ended. Consequently, he ceases to be a member of the Board and its committees.

Independent Director’s Departure

Eris Lifesciences Limited announced the completion of Mr. Rajeev Dalal’s tenure as a Non-Executive, Independent Director, effective December 18, 2025. His appointment, spanning five years, was formalized after the company’s Fifteenth Annual General Meeting.

End of Term Details

Mr. Dalal’s original appointment date was December 19, 2020. His departure marks the conclusion of his role on the Board. With the conclusion of his tenure as an Independent Director, his membership and chairmanship in the various Board committees also concluded.

Source: BSE

InvestyWise News
InvestyWise News
Covers market-moving news with speed and precision, delivering sharp insights to help readers stay ahead in the fast-paced world of stocks.

Latest articles

Related articles

Leave a reply

Please enter your comment!
Please enter your name here
Captcha verification failed!
CAPTCHA user score failed. Please contact us!